NCT03532217 2022-08-05Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate CancerWashington University School of MedicinePhase 1 Completed19 enrolled